Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04145375
Title Continuation Protocol for ZEN003694 in Patients Experiencing Clinical Benefit While Enrolled in a ZEN003694 Protocol
Recruitment Enrolling by invitation
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Zenith Epigenetics
Indications

prostate cancer

Therapies

Enzalutamide + ZEN-3694

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.